Skip to search.
 STI Down 1.77%
Streaming
Ticker Tape: On

Celldex Therapeutics, Inc. (CLDX)

-NasdaqGS

12.28 Down 0.25(2.00%) 01:55 SGT - Nasdaq Real Time Price

Add to Portfolio
Prev Close:12.53
Open:12.22
Bid:12.35 x 2000
Ask:12.36 x 200
1y Target Est:15.75
Beta:2.87
Next Earnings Date: 5-Aug-13CLDX Earnings announcement
Day's Range:12.11 - 12.68
52wk Range:3.91 - 14.09
Volume:474,597
Avg Vol (3m):1,762,410
Market Cap:993.08M
P/E (ttm):N/A
EPS (ttm):-0.99
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CLDXDown 2.00%993.08M
RHHBYN.MXUp 0.14%2.66T
SHP.LDown 0.97%11.77B
SUNPHARMA.NSUp 0.41%1.04T
GILD.MXDown 1.48%1.04T

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):90.61
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-13) :-0.95
Quarterly EPS Est (Jun-13) :-0.22
Mean Recommendation*:1.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback